The tweet was deleted by the author.
But we saved everything 🙂.
Pacific Biosciences of California is advancing genomic medicine by introducing HiFi sequencing as a solution for rare disease cases that remain unexplained after standard genetic tests.
The company brings together an expert panel to discuss how this technology can uncover genetic variations that traditional methods overlook. Along with the panel, Pacific Biosciences of California offers access to a new white paper detailing solve rates in rare disease investigations. Details about the technology, data, and opportunities for clinicians and researchers are available through the company's online resources.
View post on X Loading...
Pacific Biosciences of California recently drew interest with packed sessions and booth events at ESHG2026. The company has also made PRISM 2026 conference presentations available on demand. These efforts expand Pacific Biosciences of California's outreach to researchers and clinicians.